Erasmus MC Biomedical Fund

Erasmus MC Biomedical Fund is a venture capital firm focused on investing in biomedical companies in the Netherlands. The fund primarily targets early-stage investments, with a particular emphasis on Series A and Series B funding rounds. Their investment strategy centers on supporting innovative biomedical ventures that show promise in advancing healthcare and life sciences.

Notable in their portfolio is argenx, a biotechnology company that has raised over $50 million. The fund's close association with Erasmus Medical Center, a renowned academic medical center in Rotterdam, likely provides portfolio companies with access to cutting-edge research and clinical expertise. This connection potentially offers startups valuable resources and networking opportunities within the biomedical ecosystem.